Hong, S.D.; Katuwal, N.B.; Kang, M.S.; Ghosh, M.; Park, S.M.; Kim, T.H.; Baek, Y.S.; Lee, S.R.; Moon, Y.W.
Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Enhances Natural Killer Cell Cytotoxicity in HER2-Overexpressing Ovarian Cancer. Int. J. Mol. Sci. 2024, 25, 11733.
https://doi.org/10.3390/ijms252111733
AMA Style
Hong SD, Katuwal NB, Kang MS, Ghosh M, Park SM, Kim TH, Baek YS, Lee SR, Moon YW.
Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Enhances Natural Killer Cell Cytotoxicity in HER2-Overexpressing Ovarian Cancer. International Journal of Molecular Sciences. 2024; 25(21):11733.
https://doi.org/10.3390/ijms252111733
Chicago/Turabian Style
Hong, Sa Deok, Nar Bahadur Katuwal, Min Sil Kang, Mithun Ghosh, Seong Min Park, Tae Hoen Kim, Young Seok Baek, Seung Ryeol Lee, and Yong Wha Moon.
2024. "Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Enhances Natural Killer Cell Cytotoxicity in HER2-Overexpressing Ovarian Cancer" International Journal of Molecular Sciences 25, no. 21: 11733.
https://doi.org/10.3390/ijms252111733
APA Style
Hong, S. D., Katuwal, N. B., Kang, M. S., Ghosh, M., Park, S. M., Kim, T. H., Baek, Y. S., Lee, S. R., & Moon, Y. W.
(2024). Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Enhances Natural Killer Cell Cytotoxicity in HER2-Overexpressing Ovarian Cancer. International Journal of Molecular Sciences, 25(21), 11733.
https://doi.org/10.3390/ijms252111733